Selecting a CDMO for Preclinical Drug Development
Key considerations when choosing a CDMO partner for early-stage drug development.
1 min read582 viewsPublished August 25, 2025
Selecting a CDMO for Preclinical Drug Development
Early-Stage Considerations
Preclinical development has unique requirements that differ from later stages.
Key Selection Criteria
Scientific Expertise
- Process development capabilities
- Formulation expertise
- Analytical method development
Flexibility
- Small batch capabilities
- Rapid turnaround times
- Willingness to iterate
Regulatory Knowledge
- IND-enabling experience
- GLP compliance
- Documentation standards
Evaluation Process
- Technical assessment
- Capacity evaluation
- Team assessment
- Reference checks
Common Pitfalls
- Over-engineering for the stage
- Insufficient documentation
- Poor scalability planning
Was this article helpful?
Sign in to provide feedback